CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Aliskiren

阿利克仑 杂质对照品Aliskiren Impurities

52 个杂质条目52 impurity entries

本页汇总 阿利克仑 的 52 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 52 impurity reference standards of Aliskiren. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 阿利克仑(Aliskiren)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA stability-indicating HPLC method for the quantification of aliskiren and hydrochlorothiazide in a pharmaceutical formulation
    Journal of AOAC International · 2014 · Karvelis D et al.  ·  PMID 25632429  ·  DOI
  2. 杂质研究Impurity studiesSimultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical preparations using a validated stability-indicating MEKC method
    Journal of separation science · 2011 · Sangoi MS et al.  ·  PMID 21710580  ·  DOI
  3. 杂质研究Impurity studiesDetermination of aliskiren in tablet dosage forms by a validated stability-indicating RP-LC method
    Journal of chromatographic science · 2011 · Wrasse-Sangoi M et al.  ·  PMID 21223645  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisThe development of a complementary pathway for the synthesis of aliskiren
    Organic & biomolecular chemistry · 2015 · Li LL et al.  ·  PMID 25420597  ·  DOI
  • 合成方法SynthesisFormal total synthesis of aliskiren
    Chemistry (Weinheim an der Bergstrasse, Germany) · 2015 · Peters BK et al.  ·  PMID 25783891  ·  DOI

阿利克仑 —— 原料药与杂质对照品Aliskiren — drug substance & impurities

共 53 个条目(含原料药本体)53 items incl. the drug substance
Aliskiren structure
原料药 APIAPI
阿利克仑Aliskiren
Aliskiren
CAS No.173334-57-1
Chemical FormulaC30H53N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Acid Impurity Sodium Salt structure
SODIUM
Aliskiren Acid Impurity Sodium Salt
CAS No.—
Chemical FormulaC30H51N2O7.Na
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Hemifumarate structure
—
阿利克仑半富马酸盐Aliskiren Hemifumarate
Aliskiren Hemifumarate
CAS No.173334-58-2
Chemical FormulaC64H110N6O16
Purity>95%询价On request
10mg25mg50mg100mg
Hydroxy Aliskiren Impurity structure
—
Hydroxy Aliskiren Impurity
CAS No.—
Chemical FormulaC30H53N3O7.0.5C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Michael Adduct-1 Impurity structure
—
Aliskiren Michael Adduct-1 Impurity
CAS No.—
Chemical FormulaC34H57N3O10
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Michael Adduct-2 Impurity structure
—
Aliskiren Michael Adduct-2 Impurity
CAS No.—
Chemical FormulaC34H57N3O10
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Hemifumarate (RSSS isomer) Impurity structure
—
Aliskiren Hemifumarate (RSSS isomer) Impurity
CAS No.—
Chemical FormulaC30H53N3O6.0.5C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren-d6 Hemifumarate structure
—
阿利克仑半富马酸盐-d6Aliskiren-d6 Hemifumarate
Aliskiren-d6 Hemifumarate
CAS No.—
Chemical FormulaC30H47D6N3O6.0.5C4H4O4
Purity>95%询价On request
N-Boc Aliskiren structure
—
N-Boc Aliskiren
CAS No.—
Chemical FormulaC35H61N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Amino Lactone Impurity structure
—
Amino Lactone Impurity
CAS No.—
Chemical FormulaC25H41NO5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Hemifumarate (RRRS isomer) Impurity structure
—
Aliskiren Hemifumarate (RRRS isomer) Impurity
CAS No.—
Chemical FormulaC30H53N3O6.0.5C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Hemifumarate (SSSR isomer) Impurity structure
—
Aliskiren Hemifumarate (SSSR isomer) Impurity
CAS No.—
Chemical FormulaC30H53N3O6.0.5C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Hemifumarate Enantiomer (RRRR isomer) Impurity structure
—
Aliskiren Hemifumarate Enantiomer (RRRR isomer) Impurity
CAS No.—
Chemical FormulaC30H53N3O6.0.5C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Desmethoxy Aliskiren Impurity structure
—
Desmethoxy Aliskiren Impurity
CAS No.—
Chemical FormulaC29H51N3O5.0.5C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 1 structure
1
阿利克仑杂质1Aliskiren Impurity 1
Aliskiren Impurity 1
CAS No.1438401-04-7
Chemical FormulaC29H51N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren  Impurity 6 structure
6
阿利克仑杂质6Aliskiren Impurity 6
Aliskiren Impurity 6
CAS No.173338-07-3
Chemical FormulaC35H61N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 8 Monomer structure
8
阿利克仑杂质8 单体Aliskiren Impurity 8 Monomer
Aliskiren Impurity 8 Monomer
CAS No.173400-13-0
Chemical FormulaC30H52N2O7
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren  Impurity 10 structure
10
阿利克仑杂质10Aliskiren Impurity 10
Aliskiren Impurity 10
CAS No.1630036-82-6
Chemical FormulaC30H53N3O6·1/2(C4H4O4)
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren  Impurity 11 structure
11
阿利克仑杂质11Aliskiren Impurity 11
Aliskiren Impurity 11
CAS No.630036-76-8
Chemical FormulaC30H53N3O6·1/2(C4H4O4)
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren  Impurity 12 structure
12
阿利克仑杂质12Aliskiren Impurity 12
Aliskiren Impurity 12
CAS No.1438401-07-0
Chemical FormulaC29H51N3O5·1/2(C4H4O4)
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 14 structure
14
阿利克仑杂质14Aliskiren Impurity 14
Aliskiren Impurity 14
CAS No.866030-41-3
Chemical FormulaC30H53N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 16 structure
16
阿利克仑杂质16Aliskiren Impurity 16
Aliskiren Impurity 16
CAS No.325154-32-3
Chemical FormulaC30H53N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 26 structure
26
阿利克仑杂质26Aliskiren Impurity 26
Aliskiren Impurity 26
CAS No.1309922-73-3
Chemical FormulaC30H49NO7
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 42 structure
42
阿利克仑杂质42Aliskiren Impurity 42
Aliskiren Impurity 42
CAS No.1609187-60-1
Chemical FormulaC25H39N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 45 structure
45
阿利克仑杂质45Aliskiren Impurity 45
Aliskiren Impurity 45
CAS No.1309922-72-2
Chemical FormulaC25H39N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 47 structure
47
阿利克仑杂质47Aliskiren Impurity 47
Aliskiren Impurity 47
CAS No.325740-70-3
Chemical FormulaC25H39N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 49 structure
49
阿利克仑杂质49Aliskiren Impurity 49
Aliskiren Impurity 49
CAS No.324763-46-4
Chemical FormulaC25H39N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 50 structure
50
阿利克仑杂质50Aliskiren Impurity 50
Aliskiren Impurity 50
CAS No.1227379-43-2
Chemical FormulaC25H39N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 57 structure
57
阿利克仑杂质57Aliskiren Impurity 57
Aliskiren Impurity 57
CAS No.1630037-03-4
Chemical FormulaC25H39N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 59 structure
59
阿利克仑杂质59Aliskiren Impurity 59
Aliskiren Impurity 59
CAS No.324763-47-5
Chemical FormulaC30H51N5O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 60 structure
60
阿利克仑杂质60Aliskiren Impurity 60
Aliskiren Impurity 60
CAS No.1609187-63-4
Chemical FormulaC30H51N5O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 61 structure
61
阿利克仑杂质61Aliskiren Impurity 61
Aliskiren Impurity 61
CAS No.1609187-69-0
Chemical FormulaC30H51N5O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 63 structure
63
阿利克仑杂质63Aliskiren Impurity 63
Aliskiren Impurity 63
CAS No.1607844-94-9
Chemical FormulaC30H51N5O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 65 structure
65
阿利克仑杂质65Aliskiren Impurity 65
Aliskiren Impurity 65
CAS No.325154-31-2
Chemical FormulaC30H51N5O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 68 structure
68
阿利克仑杂质68Aliskiren Impurity 68
Aliskiren Impurity 68
CAS No.1609187-65-6
Chemical FormulaC30H51N5O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 73 structure
73
阿利克仑杂质73Aliskiren Impurity 73
Aliskiren Impurity 73
CAS No.1873293-95-8
Chemical FormulaC30H51N5O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 75 structure
75
阿利克仑杂质75Aliskiren Impurity 75
Aliskiren Impurity 75
CAS No.173335-55-2
Chemical FormulaC32H57N3O7
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 76 structure
76
阿利克仑杂质76Aliskiren Impurity 76
Aliskiren Impurity 76
CAS No.179559-07-0
Chemical FormulaC6H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 77 structure
77
阿利克仑杂质77Aliskiren Impurity 77
Aliskiren Impurity 77
CAS No.87060-66-0
Chemical FormulaC6H10N2O
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 78 structure
78
阿利克仑杂质78Aliskiren Impurity 78
Aliskiren Impurity 78
CAS No.393108-57-1
Chemical FormulaC25H39BrO5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 79 structure
79
阿利克仑杂质79Aliskiren Impurity 79
Aliskiren Impurity 79
CAS No.387353-77-7
Chemical FormulaC9H15ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 80 structure
80
阿利克仑杂质80Aliskiren Impurity 80
Aliskiren Impurity 80
CAS No.387353-71-1
Chemical FormulaC26H42O5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 81 structure
81
阿利克仑杂质81Aliskiren Impurity 81
Aliskiren Impurity 81
CAS No.365541-74-8
Chemical FormulaC23H27NO4
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 82 structure
82
阿利克仑杂质82Aliskiren Impurity 82
Aliskiren Impurity 82
CAS No.172900-83-3
Chemical FormulaC24H39NO6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 83 structure
83
阿利克仑杂质83Aliskiren Impurity 83
Aliskiren Impurity 83
CAS No.949925-74-0
Chemical FormulaC29H51N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 84 structure
84
阿利克仑杂质84Aliskiren Impurity 84
Aliskiren Impurity 84
CAS No.949925-77-3
Chemical FormulaC26H45N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 85 structure
85
阿利克仑杂质85Aliskiren Impurity 85
Aliskiren Impurity 85
CAS No.949925-75-1
Chemical FormulaC29H49N3O7
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 86 structure
86
阿利克仑杂质86Aliskiren Impurity 86
Aliskiren Impurity 86
CAS No.1236549-06-6
Chemical FormulaC38H59N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 87 Hydrochloride-d6 structure
87
阿利克仑杂质87 盐酸盐-d6Aliskiren Impurity 87 Hydrochloride-d6
Aliskiren Impurity 87 Hydrochloride-d6
CAS No.1246815-96-2
Chemical FormulaC30H47D6N3O6·HCl
Purity>95%询价On request
Aliskiren Impurity 87 structure
87
阿利克仑杂质87Aliskiren Impurity 87
Aliskiren Impurity 87
CAS No.2104801-40-1
Chemical FormulaC30H53N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Aliskiren Impurity 59-d3 structure
59-D3
阿利克仑杂质59-d3Aliskiren Impurity 59-d3
Aliskiren Impurity 59-d3
CAS No.1227379-67-0
Chemical FormulaC30H48D3N5O6
Purity>95%询价On request
Aliskiren Impurity 59-d6 structure
59-D6
阿利克仑杂质59-d6Aliskiren Impurity 59-d6
Aliskiren Impurity 59-d6
CAS No.1227379-87-4
Chemical FormulaC30H45D6N5O6
Purity>95%询价On request
Aliskiren Impurity 59-d6A structure
59-D6A
阿利克仑杂质59-d6AAliskiren Impurity 59-d6A
Aliskiren Impurity 59-d6A
CAS No.2714484-68-9
Chemical FormulaC30H45D6N5O6
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

阿利克仑 —— 研究文献与合成路线Aliskiren — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 阿利克仑 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Aliskiren. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Rapid HILIC method with fluorescence detection using derivatization reaction utilizing o-phthaldialdehyde for determination of degradation product of aliskiren
    Douša M, Břicháč J, Svoboda J, et al. · Journal of pharmaceutical and biomedical analysis · 2012 · 被引 9cited 9
  2. Characterization of solution stress degradation products of aliskiren and prediction of their physicochemical and ADMET properties
    Kushwah BS, Gupta J, Singh DK, et al. · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2018 · 被引 5cited 5
  3. Simultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical preparations using a validated stability-indicating MEKC method
    Sangoi MS, Wrasse-Sangoi M, Oliveira PR, et al. · Journal of separation science · 2011 · 被引 11cited 11
  4. Determination of aliskiren in tablet dosage forms by a validated stability-indicating RP-LC method
    Wrasse-Sangoi M, Sangoi MS, Oliveira PR, et al. · Journal of chromatographic science · 2011 · 被引 9cited 9
  5. A stability-indicating HPLC method for the quantification of aliskiren and hydrochlorothiazide in a pharmaceutical formulation
    Karvelis D, Kalogria E, Panderi I, et al. · Journal of AOAC International · 2014 · 被引 4cited 4

合成与制备工艺专利Synthesis & process patents

  1. ALISKIREN INTERMEDIATES AND A PROCESS FOR ANALYZING THE PURITY OF ALISKIREN
    ETINGER MARINA, SHARABI MEITAL, MITTELMAN ARIEL, RONEN YIFAT, et al. · 公开号 WO2012034065WO2012034065 · 2012
  2. INTERMEDIATES FOR SYNTHESIS OF ALISKIREN AND THEIR PREPARATION
    ZHANG FUYAO, SUN PIAOYANG · 公开号 WO2011127797WO2011127797 · 2011
  3. SYNTHESIS OF ALISKIREN
    RAMA SHANKAR, VADALI LAKSHMANA RAO, PALLA VIJAY KUMAR, SAIDUGARI SWAMY, et al. · 公开号 WO2012052829WO2012052829 · 2012
  4. PROCESS FOR PREPARING ALISKIREN AND ITS INTERMEDIATES
    KOLLA NAVEEN KUMAR, APPAYE KALIYAPERUMAL SRINIVASAN, GANGULA SRINIVAS, GOVINDAPUR RAJESHWAR REDDY, et al. · 公开号 WO2012021446WO2012021446 · 2012
  5. PROCESS FOR PRODUCING ALISKIREN
    TADDEI MAURIZIO, RUSSO ADELE, CINI ELENA, RIVA RENATA, et al. · 公开号 WO2011151442WO2011151442 · 2011

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

阿利克仑 杂质谱研究要点Aliskiren — impurity profiling notes

下面这些是拿到 阿利克仑 的 53 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 53 impurity entries for Aliskiren, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances